Navigation Links
No Lymphoma Risk From Rheumatoid Arthritis Drugs

There has been an increasing fear regarding the elevated risk of lymphoma associated with rheumatoid arthritis treatment// A new study by Swedish researchers has found that such treatments may not confer an increased susceptibility to cancer, the results of which can be seen in the latest issue of Arthritis & Rheumatism journal.

The risk of cancer has been found to increase with worsening of the chronic inflammatory process. In other words, a cause-effect relationship has been established with the disease severity and cancer risk. Infact the drugs given for symptomatic treatment of rheumatoid arthritis, which, prevent further progress of the inflammation may actually reduce the cancer risk.

Rheumatoid arthritis is a progressive disease, characterized by inflammation of joints resulting in pain, joint damage, immobility and finally disability. Nearly 2 million Americans have been diagnosed with the chronic disease, according to estimates by the Arthritis Foundation. Non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biologic response modifiers (new generation drugs) and analgesics are currently being given for treatment.

The researchers studied data obtained from nearly 75,000 rheumatoid arthritis patients. Amongst these, 378 patients developed lymphoma during the course of treatment. The data obtained was compared with that obtained from 378 healthy controls. The severity of the disease (low, medium, high), the duration of the disease, the level of inflammation or tenderness in the joints was some of the factors taken into consideration.

The results of the analysis established that individuals with high activity (severe disease) had a 70-fold increased risk of developing lymphoma. The severity of involvement of knees, hands and feet within the first year of diagnosis was also found to confer an increased risk. The lymphoma risk was much lower (8 fold) in those who ha d medium disease activity.

Furthermore, no increased risk of lymphoma was found in those who were given anti-rheumatic drugs (DMARDS), including the drug methotrexate (anti-cancer drug). No increased risk could also be documented with use of steroids or NSAIDs. Surprisingly, the incidence of lymphoma in those who were given corticosteriods injections was the lowest, probably highlighting its role in cancer prevention.

The results of the present study highlight the need for early identification and aggressive treatment to prevent worsening of the disease. To conclude, the more severe the disease, the higher is the cancer risk. The provision of appropriate anti-rheumatic treatment can decrease the disease related complications.


'"/>




Related medicine news :

1. Lymphomas Link to Hepatitis C
2. New Guidelines For Assessing Lymphoma Treatment
3. A Novel Treatment for KSHV-infected Lymphomas
4. New treatment for Rheumatoid Arthritis
5. New Rheumatoid Arthritis Treatment
6. New Rheumatoid Arthritis Treatment
7. Consumption Of Red Meat Found To Double The Risk of Rheumatoid Arthritis
8. The Link Between Rheumatoid Arthritis And Heart Failure
9. Smoking during pregnancy increases risk of Rheumatoid Arthritis.
10. Good News For Those Of You Suffering From Rheumatoid Arthritis
11. Mineral Oil exposure increases risk of Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: